Vascular endothelial growth factor levels and induction of permeability in malignant pleural effusions

Clinical Cancer Research

Volumn 5, Issue 11, 1999, Pages 3364-3368

  Zebrowski, Brian K ^a   Yano, Seiji ^a   Liu, Wenbiao ^a   Shaheen, Raymond M ^a   Hicklin, Daniel J ^b   Putnam Jr , Joe B ^a   Ellis, Lee M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIN; ANTIBODY; CYTOKINE; INTERLEUKIN 8; VASCULOTROPIN;

ANIMAL MODEL; ARTICLE; BLOOD VESSEL PERMEABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; IMMUNOASSAY; MALIGNANT NEOPLASTIC DISEASE; MOUSE; NONHUMAN; PLEURA EFFUSION; PRIORITY JOURNAL;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; BREAST NEOPLASMS; CAPILLARY PERMEABILITY; CARCINOMA, NON-SMALL-CELL LUNG; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; INTERLEUKIN-8; LUNG NEOPLASMS; LYMPHOKINES; LYMPHOMA; MALE; MESOTHELIOMA; MICE; MICE, NUDE; PLEURAL EFFUSION, MALIGNANT; PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RECOMBINANT PROTEINS; RIBONUCLEASE, PANCREATIC; SARCOMA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0032713925     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Belani, C. P., Pajeau, T. S., and Bennett, C. L. Treating malignant pleural effusions cost consciously. Chest, 113: 78S-85S, 1998.
2. Luciani, M. G., Stoppacciaro, A., Peri, G., Mantovani, A., and Ruco, L. P. The monocyte chemotactic protein a (MCP-1) and interleukin 8 (IL-8) in Hodgkin's disease and in solid tumors. Mol. Pathol., 51: 273-276, 1998.
3. Rusch, V. W. The optimal treatment of malignant pleural effusions. A continuing dilemma. Chest, 100: 1483-1484, 1991.
4. Fenton, K. N., and Richardson, J. D. Diagnosis and management of malignant pleural effusions. Am. J. Surg., 170: 69-74, 1995.
5. Kraft, K., Weindel, K., Ochs, A., Marth, C., Zmija, J., Schumacher, P., Unger, C., Marrne, D., and Gastl, G. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease. Cancer (Phila.), 85: 178-187, 1999.
6. Ceyhan, B. B., Ozgun, S., Celikel, T., Yalcin, M., and Koc, M. IL-8 in pleural effusion. Respir. Med., 90: 215-221, 1996.
7. Aboulghar, M. A., Mansour, R. T., Serour, G. I., Elhelw, B. A., and Shaarawy, M. Elevated concentrations of angiogenin in serum and ascitic fluid from patients with severe ovarian hyperstimulation syndrome. Hum. Reprod., 13: 2068-2071, 1998.
8. Brown, L. F., Berse, B., Jackman, R. W., Tognazzi, K., Manseau, E. J., Senger, D. R., and Dvorak, H. F. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res., 53: 4727-4735, 1993.
9. Brown, L. F., Berse, B., Jackman, R. W., Tognazzi, K., Manseau, E. J., Dvorak, H. F., and Senger, D. R. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am. J. Pathol., 143: 1255-1262, 1993.
10. Ferrara, N., Houch, K. A., Jackeman, L. B., Winer, J., and Leung, D. W. The vascular endothelial growth factor family of polypeptides. J. Cell. Biochem., 47: 211-218, 1991.
11. Dvorak, H. F., Nagy, J. A., Berse, B., Brown, L. F., Yeo, K. T., Yeo, T. K., Dvorak, A. M., Van De Water, L., Sioussat, T. M., and Senger, D. R. Vascular permeability factor, fibrin, and the pathogensis of tumor stroma formation. Ann. NY Acad. Sci., 667; 101-111, 1992.
12. Collins, P. D., Connolly, D. T., and Williams, T. J. Characterization of the increase in vascular permeability induced by vascular permeabilty factor in vivo. Br. J. Pharmacol., 109: 195-199, 1993.
13. Abromov, Y., Barak, V., Nisman, B., and Schenker, J. G. Vascular edothelial growth factor plasma levels correlate to the clinical picture n severe ovarian hyperstimulation syndrome. Fertil. Steril., 67: 261-265, 1997.
14. Zebrowski, B. K., Liu, W., Ramirez, K., Akagi, Y., Mills, G. B., and Ellis, L. M. Markedly elevated levels of vascular endothelial growth factor in malignant ascites. Ann. Surg. Oncol., 6: 373-378, 1999.
15. Bar-Eli, M. Role of interleukin-8 in tumor growth and metastasis of human melanoma. Pathobiology, 67: 12-18, 1999.
16. Eisma, R. J., Spiro, J. D., and Kreutzer, D. L. Role of angiogenic factors: coexpression of interleukin-8 and vascular endothelial growth factor in patients with head and neck squamous carcinoma. Laryngoscope, 109: 687-693, 1999.
17. Chopra, V., Dinh, T. V., and Hannigan, E. V. Angiogenin, interleukins, and growth-factor levels in serum of patients with ovarian cancer: correlation with angiogenesis. Cancer J. Sci. Am., 2: 279, 1996.
18. Witte, L., Hicklin, D. J., Zhu, Z., Pytowski, B., Kotanides, H., Rockwell, P., and Bohlen, P. Monoclonal antibodies targeting the VEGF receptor-2 (Flk1/KDR) as an anti-angiogenic therapeutic strategy. Cancer Metastasis Rev., 17: 155-161, 1998.
19. Murohara, T., Horowitz, J. R., Silver, M., Tsurumi, Y., Chen, D., Sullivan, A., and Isner, J. M. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation, 97: 99-107, 1998.
20. Ivarsson, K., Runesson, E., Sundfeldt, K., Haeger, M., Hedin, L., Janson, P. O., and Brannstrom, M. The chemotactic cytokine interleukin-8-a cyst fluid marker for malignant epithelial ovarian cancer? Gynecol. Oncol., 71: 420-423, 1998.